Therefore, Liu and colleagues conjugated photosensitizer IRDye700 with the Fab fragment of an anti-CD276 antibody to combine antiangiogenic therapy and PDT with PD-1/PD-L1 blockade to treat primary tumors and ablation of tumor metastases. This evidence concerns the gene CD276 and neoplasm.